BioFire Defense

Next Mission Ready: The BioThreat Panel is coming to SPOTFIRE®! The comprehensive BioThreat Panel is landing on the agile BIOFIRE® SPOTFIRE® System this December. This powerful combination delivers accuracy and reliability in an easy-to-use, scalable PCR system, ensuring the speed necessary to mitigate threats and protect communities. Learn how this agile, fast-deployment technology helps responders make informed decisions when time is critical. Learn more here: https://lnkd.in/gbuherUt #SPOTFIRE #BiothreatDetection #NewCapability #Readiness

Innovation is key to operational readiness. BIOFIRE® FILMARRAY® 2.0 System delivers comprehensive syndromic testing through an automated workflow, ensuring high-confidence pathogen identification. Multi-target accuracy, a single test, diagnostic intelligence when time is critical. Learn More: https://lnkd.in/gdxBuFYf

BioFire Defense provides the confidence of a stable supply chain and dedicated compliance necessary for critical military and government healthcare settings.

On October 3, 1990, BioFire Defense began with a mission: to push the boundaries of Molecular Biology. 35 years later, that mission continues. From pioneering PCR-based technology to supporting global health security, BioFire Defense is committed to innovation, operational readiness, and trusted performance in mission-critical environments. We’re proud of our past. We’re ready for the future. Learn more about our history at https://lnkd.in/gwkcpEkC

Most clinicians know BioFire for fast, reliable respiratory and GI testing in central labs. But if that's all your facility is running, you're only tapping into a fraction of what your system can do. Because the BIOFIRE® FILMARRAY® ecosystem uses a standardized pouch design, the same system sitting in your lab can solve critical diagnostic challenges across entirely different medical departments: The BIOFIRE Pneumonia Panel targets 33 pathogens including several resistance genes in about an hour, giving critical care teams immediate answers to guide targeted therapy and support antimicrobial stewardship. The BIOFIRE®️Meningitis/Encephalitis Panel tests spinal fluid for 14 pathogens at once, helping clinicians rule out critical central nervous system infections in a single run. The BIOFIRE®️Blood Culture Identification 2 Panel tests a single positive blood culture sample to simultaneously provide results for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes. Unlocking these capabilities doesn't require new hardware or complex contract negotiations. With BioFire Defense expanding your facility's diagnostic reach is as simple as adding a new panel. See how much more your BIOFIRE platform can handle: https://lnkd.in/g6-Fcw9d BioFire Defense is the sole supplier of bioMérieux's BIOFIRE product line to the United States Department of War, Defense Health Agency, and other federal agencies. #ForceHealthProtection #CriticalCare #SyndromicTesting #BioFireDefense

When a patient in a Military Health System critical care unit spikes a fever, clinicians enter a race against the clock. Standard blood culture protocols can take two to three days to isolate a pathogen and determine antibiotic susceptibility. In the interim, broad-spectrum antibiotics are deployed out of necessity, leaving clinicians to treat in the dark while the risk of sepsis progression and drug resistance climbs. A partnership with BioFire Defense changes that timeline. Using a single positive blood culture sample, the BIOFIRE® Blood Culture Identification 2 Panel tests for 43 targets associated with bloodstream infections in about an hour. Instead of waiting days to de-escalate treatment, critical care teams quickly get the answers required to initiate targeted therapy, protect patient outcomes, and enforce antimicrobial stewardship on day one. Cut diagnostic uncertainty out of your critical care workflow: https://lnkd.in/g6-Fcw9d